IRIS
GIALLONGO, CESARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.744
EU - Europa 2.209
AS - Asia 910
AF - Africa 269
SA - Sud America 171
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.307
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.690
IT - Italia 1.433
SG - Singapore 493
IE - Irlanda 286
CN - Cina 280
CI - Costa d'Avorio 205
BR - Brasile 152
UA - Ucraina 131
DE - Germania 91
RU - Federazione Russa 55
VN - Vietnam 50
CA - Canada 49
SN - Senegal 49
FR - Francia 37
SE - Svezia 31
FI - Finlandia 30
GB - Regno Unito 28
CZ - Repubblica Ceca 19
NL - Olanda 19
JP - Giappone 18
BE - Belgio 15
IN - India 13
CH - Svizzera 9
EC - Ecuador 9
HK - Hong Kong 7
KR - Corea 7
LB - Libano 7
NG - Nigeria 6
AR - Argentina 5
GR - Grecia 5
BD - Bangladesh 4
IL - Israele 4
MA - Marocco 4
MX - Messico 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AU - Australia 3
IQ - Iraq 3
NO - Norvegia 3
TR - Turchia 3
AL - Albania 2
ES - Italia 2
LT - Lituania 2
PK - Pakistan 2
PL - Polonia 2
TN - Tunisia 2
AM - Armenia 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MK - Macedonia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 6.307
Salva come PNG Salva come JPEG
Città #
Santa Clara 636
Chandler 453
Catania 389
Singapore 338
Chicago 284
Dublin 283
Abidjan 204
Jacksonville 155
Boardman 123
Ashburn 104
Civitanova Marche 91
Florence 79
Houston 73
Cambridge 68
Lawrence 68
Andover 64
Rome 60
Dakar 49
Dong Ket 44
Nanjing 42
Milan 39
Toronto 37
Des Moines 36
Munich 34
Palermo 29
Beijing 26
Misterbianco 26
Bremen 25
Bronte 25
Wilmington 24
Messina 21
Brno 19
Helsinki 19
Saint Petersburg 19
San Mateo 19
Falls Church 18
Nanchang 18
Shenyang 17
Council Bluffs 16
Washington 16
Dearborn 14
Fukuoka 14
Brussels 13
Turin 13
Hebei 12
Augusta 11
Bari 11
Lappeenranta 11
Ottawa 11
Paris 11
Los Angeles 10
Seattle 10
Changsha 9
Guangzhou 9
Jiaxing 9
Moscow 9
São Paulo 9
Aci Catena 8
Acireale 8
Tianjin 8
Genoa 7
Hanover 7
Hong Kong 7
Ragusa 7
San Giovanni la Punta 7
Seoul 7
Abuja 6
Den Haag 6
Hanoi 6
Torino 6
Vicenza 6
Amsterdam 5
Floridia 5
Grafing 5
Jinan 5
Naples 5
Padova 5
Aachen 4
Agrate Brianza 4
Bernareggio 4
Capri Leone 4
Forcoli 4
Gallipoli 4
Giarre 4
Kunming 4
Lentini 4
Mascalucia 4
Nola 4
Pedara 4
Quito 4
Reggio Calabria 4
Tel Aviv 4
Ann Arbor 3
Belo Horizonte 3
Belpasso 3
Bergamo 3
Casablanca 3
Cassano delle Murge 3
Fremont 3
Hyderabad 3
Totale 4.486
Salva come PNG Salva come JPEG
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 164
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 159
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 131
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 129
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 124
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib 110
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 110
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 105
Biological properties of itraconazole-SLN 99
Focus on Osteosclerotic Progression in Primary Myelofibrosis 98
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing 98
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 93
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 90
Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation 89
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 88
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 87
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 86
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 86
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 84
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells 82
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 81
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 81
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance 80
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 80
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma 79
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 79
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 77
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 77
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 76
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 76
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 76
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 75
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 74
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 74
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 73
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 73
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 71
Hedgehog signaling pathways in multiple myeloma 71
Biological properties of itraconazole-SLNs 70
Pericytes in microvessels: From “mural” function to brain and retina regeneration 70
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 69
Effects of imatinib mesylate in osteoblastogenesis 69
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 69
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 67
Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients 66
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 65
Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project 65
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 64
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 63
Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells 63
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype 61
The Heme Oxygenase System in Hematological Malignancies 61
Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture 60
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 60
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 59
Myeloid-derived suppressor cells in Chronic myeloid leukemia 59
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 59
Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors 59
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 59
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 59
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 57
GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS 57
The Role of Epigenetics in Neuroinflammatory-Driven Diseases 56
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 55
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. 54
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 54
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models 53
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 53
OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE 52
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 51
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 50
IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA 46
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 45
Proteasome inhibitors as a possible therapy for SARS-CoV-2 45
Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients 45
The Role of Inflammation and Inflammasome in Myeloproliferative Disease 45
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells 44
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 44
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Corneal Epithelial Cells against UV-B-Induced Apoptosis via ROS/JNK Pathway Inhibition 44
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 43
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 43
LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS 43
Monocytic myeloid derived suppressor cells in hematological malignancies 43
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 41
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients 40
Uveal melanoma cells elicit retinal pericyte phenotypical and biochemical changes in an in vitro model of coculture 38
Correction to: Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models (Antioxidants, (2022), 11, 8, (1596), 10.3390/antiox11081596) 37
Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. 37
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC) 35
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome 35
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 33
The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms 33
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis 30
Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity 23
Mesenchymal Stromal Cells (MSC) As Key Players in the Tumor Microenvironment Transformation from MGUS to Myeloma 22
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 21
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION 21
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 19
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells 17
IMMUNE ESCAPE MECHANISMS IN HEMATOLOGICAL DISEASES: ROLE OF THE MYELOID DERIVED SUPPRESSOR CELLS AND TUMOR MICROENVIRONMENT 17
Totale 6.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 0 0 0 0 0 0 0 0 0 0 49 27
2020/2021466 19 19 35 32 111 16 61 11 30 7 49 76
2021/2022653 41 77 10 4 116 26 101 49 51 31 18 129
2022/20231.368 96 112 40 144 111 188 19 237 267 44 71 39
2023/2024928 55 140 39 40 47 203 40 88 4 25 168 79
2024/20252.427 42 456 155 198 522 357 157 136 175 226 3 0
Totale 6.505